The role of assessment of quality of life and health with the index of vital activity in patients with arterial hypertension combined with gout in the family doctor practice.

Authors

  • O. M. Lazarenko
  • A. P. Kuzmina

DOI:

https://doi.org/10.26641/2307-0404.2018.1(part2).126940

Keywords:

hypertension, gout, quality of life, urat-lowering therapy

Abstract

The number of studies that assess the quality of life of patients with various comorbid diseases is increasing annually. Arterial hypertension and gout is no exception. There are difficulties in managing this category of patients at the primary stage in accordance with current recommendations. The purpose of the study was to analyze the effectiveness of use of questionnaires for assessing the quality of life (SF-36) and health (HAQ) with disability index (DI) in patients with arterial hypertension combined with gout in everyday clinical practice by the family doctor; to assess the correctness of maintaining this category of patients in accordance with current recommendations (EULAR, 2016). A sociological survey of general practitioners (n=30) was carried out by a specially developed questionnaire consisting of three sections. It was found that not all doctors prescribe an adequate dose of colchicine for exacerbation of gouty arthritis, and more than half of the doctors do not use preventive colchicine for 3-6 months after the attack. Most doctors do not use the assessment quality of life (SF-36) and Health Assessment Questionare (HAQ) with a disability index (DI) at admission, but most believe that the results of these questionnaires contain important information on the patient's condition and the prospects for their using at the outpatient stage.

Author Biographies

O. M. Lazarenko

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of therapy, cardiology and family medicine of FPE
30-rіchchja Peremogi str., 2, Krivoy Rog, Dnipropetrovsk region, 50000, Ukraine

A. P. Kuzmina

SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»
Department of therapy, cardiology and family medicine of FPE
30-rіchchja Peremogi str., 2, Krivoy Rog, Dnipropetrovsk region, 50000, Ukraine

References

Amirdzhanova VI. [Methodological issues valida­tion of the Russian-language version Health Assessment Questionnaire (HAQ)]. Nauchno-prakticheskaya revmato­logiya. 2004;2:59-64. Russian.

YakimenkoIL. [Features of arterial hypertension combined with gout in men]. Ukraїns'kiy revmato­logіchniy zhurnal. 2014;1(55):62-65. Russian.

Chandratre P, Roddy Е, Clarson L. Health-related quality of life in gout: a systematic review. Rheuma­tology. 2013;52(11):2031-40.

Jeyaruban A, Larkins S, Soden M. Management of gout in general practice: a systematic review. J. Clin. Rheumatol. 2015;34:9-16.

Kiadaliri A, Uhlig T, Englund M. Burden of gout in the Nordic region, 1990-2015: findings from the Global Burden of Disease Study 2015. Scand. J. Rheumatol. 2018;1-8. doi: 10.1080/ 03009742.2017.1405461

Kim J, Kwak S, Park S. Prescription pattern of urate-lowering therapy in Korean gout patients: data from the national health claims database. Korean J. Intern. Med. 2018;33:228-9.

Pan A, Teng G, Yuan J. Bidirectional association between self-reported hypertension and gout: The Sin­ga­po­re Chinese Health Study. PLoS One. 2015;10(10):e0141749. doi: 10.1371/journal.pone.0141749

Richette P, Doherty M, Pascual E. 2016 updated EULAR evidence-based recommendations for the mana­gement of gout. Annals of the Rheumatic Diseases; 2016. Available from: http://ard.bmj.com/content/early/­2016/07/25/annrheumdis-2016-209707.full.pdf+html

Terrill M, Riordan J. A survey of the assessment and management of gout in general practitioners and medical officers within the IllawarraNetwork,Australia. Int. J. Rheum. Dis. 2017;20(8):990-95.

How to Cite

1.
Lazarenko OM, Kuzmina AP. The role of assessment of quality of life and health with the index of vital activity in patients with arterial hypertension combined with gout in the family doctor practice. Med. perspekt. [Internet]. 2018May4 [cited 2024Dec.29];23(1(part2):44-7. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/126940

Issue

Section

CLINICAL MEDICINE